The COVID-19 pandemic has challenged the conventional
diagnostic
field and revealed the need for decentralized Point of Care (POC)
solutions. Although nucleic acid testing is considered to be the most
sensitive and specific disease detection method, conventional testing
platforms are expensive, confined to central laboratories, and are
not deployable in low-resource settings. CRISPR-based diagnostics
have emerged as promising tools capable of revolutionizing the field
of molecular diagnostics. These platforms are inexpensive, simple,
and do not require the use of special instrumentation, suggesting
they could democratize access to disease diagnostics. However, there
are several obstacles to the use of the current platforms for POC
applications, including difficulties in sample processing and stability.
In this review, we discuss key advancements in the field, with an
emphasis on the challenges of sample processing, stability, multiplexing,
amplification-free detection, signal interpretation, and process automation.
We also discuss potential solutions for revolutionizing CRISPR-based
diagnostics toward sample-to-answer diagnostic solutions for POC and
home use.